Mehabe score: 3 G Factor: 4 Piotski Score: 5 The stock has a rating HOLD. The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 4 and Piotski score of 5.
Description
Choksi Imaging is engaged in the business primarily dealing in manufacturing of x-ray films & trading into specialty x-ray films & medical equipment.Site:530427Main Symbol:CHOKSI
Stock trades at 40.2, above its 50dma 31.31. It also trades above its 200dma 25.68. The stock remains bullish on techicals
The 52 week high is at 43.75 and the 52week low is at 13.00
Price Chart
P/E Chart
Sales and Margin
Strengths
– is almost debt free.
-Stock is trading at 0.90 times its book value
-Stock is providing a good dividend yield of 6.21%.
-Debtor days have improved from 81.40 to 33.12 days.
Weakness
– Promoter holding has decreased over last quarter: -2.78%
-The company has delivered a poor sales growth of -24.84% over past five years.
-Promoter holding is low: 38.51%
– has a low return on equity of 3.94% for last 3 years.
-Contingent liabilities of Rs.16.80 Cr.
-Earnings include an other income of Rs.4.02 Cr.
Competition
– The industry trades at a mean P/E of 14.8x. Choksi Imaging trades at the industry’s max P/E of 20.66x. 530427 trades at a P/E of 20.7x
– Industry’s mean G-Factor is 4.7 while the mean Piotski score is 6.0. 530427 has a G-Factor of 4 and Piotski scoreof 5.
– Average 1 month return for industry is 7.0%. The max 1- month return was given by Photoquip India: a return of 8.56 %
Quarterly Results
Sales for period ended Sep 2021 is Rs 0.27 cr compared to Rs 2.54 cr for period ended Sep 2020, a fall of 89.4%
Company reported negative operating profit of Rs -0.35 cr for period ended Sep 2021. For same period last year, operating profit was -0.04
The EPS for Sep 2021 was Rs 1.18 compared to Rs -1.41 for previous quarter ended Jun 2021 and Rs 3.23 for Sep 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 6.4 cr for period ended TTM vis-vis sales of Rs 11.02 cr for the period ended Mar 2021, a fall of 72.2%. The 3 year sales cagr stood at -28.3%.
Operating margins shrank to -36.72% for period ended TTM vis-vis -16.61% for period ended Mar 2021, contraction of 2011.0 bps.
Net Profit reported at Rs 0.76 cr for period ended TTM vis-vis sales of Rs 1.91 cr for the period ended Mar 2021, falling 151.3%.
Company reported a poor Net Profit CAGR of -4.0% over the last 3 years
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 12.0% compared to 4.0% over the last 3 Years. – The stock has given a return of 180% on a 1 Year basis vis-vis a return of 24% over the last 3 Years. – The compounded sales growth on a TTM bassis is -49% vis-vis a compounded sales growth of -22% over the last 3 Years. – The compounded profit growth on a TTM basis is 153% vis-vis a compounded profit growth of 20% over the last 3 Years.
Ratios
Shareholding Pattern
– Public shareholding has risen for the period ended Sep 2021. The Sep 2021 public holding stood at 61.49% vis-vis 58.71% for Jun 2021
Conclusion
– is almost debt free.
-Stock is trading at 0.90 times its book value
-Stock is providing a good dividend yield of 6.21%.
-Debtor days have improved from 81.40 to 33.12 days. – Promoter holding has decreased over last quarter: -2.78%
-The company has delivered a poor sales growth of -24.84% over past five years.
-Promoter holding is low: 38.51%
– has a low return on equity of 3.94% for last 3 years.
-Contingent liabilities of Rs.16.80 Cr.
-Earnings include an other income of Rs.4.02 Cr.
The business fundamentals of the stock remain stable. Stronger near term results will build interest in the stock. We suggest to wait for a upturn in business performance.
Technically, the stock remains above its 50 DMA 31.31 and is trading at 40.2, thus bullish price action wise.
